Investors in Cove Capital DSTs and Other Private Placements May Have Arbitration Claims

Investors in private placement securities, including Cove Capital’s 1031 DST Investments, may have legal claims if their investment was recommended by a financial advisor who lacked a reasonable basis for the recommendation or if the nature of the investment was misrepresented by the stockbroker or advisor.

Cove Capital Investments, based in California, sponsors a range of Delaware Statutory Trust offerings marketed to 1031 exchange investors. This article discusses the characteristics of Delaware Statutory Trust (DST) investments sponsored by Cove Capital Investments, and why investors who were recommended these or similar products by a financial advisor should carefully examine whether that recommendation was appropriate.

1031 DSTs Explained

A 1031 DST investment has three distinct elements.

First, a 1031 Exchange is a tax mechanism that allows a taxpayer who sells business or investment real estate to defer capital gains taxes by reinvesting the proceeds into a qualifying replacement property within a defined timeframe.

Second, a Delaware Statutory Trust (DST) is a legal entity created under Delaware law that holds title to real estate and allows multiple investors to own fractional shares of a property.

Third, these investments are typically sold as private placement offerings — marketed directly to selected investors rather than through public markets — and therefore are not subject to the same regulatory requirements as publicly registered securities.

Together, these features allow investors to purchase fractional interests in institutional-grade real estate — such as warehouses, medical facilities, or net lease properties — and collect income proportionate to their ownership share.

Cove Capital’s Role in the DST Market

According to its website, Cove Capital specializes in providing accredited investors with access to debt-free investment options for their 1031 exchange and direct cash investments. According to its SEC filings, the firm has sponsored numerous offerings, including:

• Cove Net Lease Distribution 44 DST
• Cove LaPlace Dialysis 26 DST
• Cove Shreveport Pharmacy DST
• Cove Essential Missouri 27 DST
• Cove Thistlewood Townhomes DST
• Cove Austin 305 Flats, LLC
• Cove Dulles Distribution DST
• Cove Missoula Multifamily DST
• Cove Essential Net Lease 32 DST
• Cove E-Commerce Distribution DST
• Cove Essential Net Lease 24 DST
• Cove Houston Multifamily 42 DST
• Cove Essential Net Lease 25 DST
• Cove Omaha MSA DST
• Cove Seattle Multifamily DST
• Cove Cocoa Dialysis 31 DST
• Cove Wyoming Distribution DST
• Cove Phoenix Pharmacy DST
• Cove NYC Metro DST
• Cove Airport Distribution 21 DST
• Cove Texas Industrial DST
• Cove Atlanta Medical DST
• Cove Florida Dialysis 22 DST
• Cove Multifamily Income Fund 28, LLC
• Cove Louisville Industrial 19 DST
• Cove Medical Net Lease 43 DST
• Cove DC MSA Medical DST
• Cove San Antonio Multifamily 29, LLC
• Cove Greenville 17 DST
• Cove Fast Food 16 DST
• Cove Essential Net Lease 30 DST
• Cove Net Lease Income Fund 18, LLC
• Cove San Antonio Multifamily 33 DST
• Cove Airport Medical DST
• Cove Debt Free Charlotte Pharmacy DST
• Cove Debt Free Maplewood Industrial DST
• Cove Debt Free Maryland Medical DST
• Cove Debt Free Tacoma Data Center DST
• Cove Debt Free Washington Pharmacy DST
• Cove Debt Free Winston-Salem Distribution DST

The Risks Brokers May Not Fully Disclose

While the tax benefits of a 1031 DST can be appealing, these investments carry significant risks that brokers do not always adequately explain. DST investors have no control over management decisions, cannot refinance or sell the underlying property at will, and may be locked into the investment for seven to ten years or more with little ability to exit early. Unlike direct real estate ownership, DST investors are entirely dependent on the sponsor to manage the asset and navigate changing market conditions.

These investments are also sold as private placements, which means they are generally speculative and illiquid compared to publicly traded securities. Despite these risks, private placements have been popular among certain broker-dealer firms because they generate substantially higher commissions. Total fees, which include commissions, due diligence, and other upfront costs, can range from 7% to 12%, creating financial incentives that may not always align with the investor’s best interests.

When a Recommendation May Give Rise to a Claim

As members of FINRA, brokerage firms and their financial advisors are obligated to perform adequate due diligence before recommending any investment, ensure that investors are fully informed of the risks involved, and conduct a suitability analysis to confirm that the investment aligns with the investor’s stated investment objectives and other criteria, including the investor’s risk tolerance and investment objectives. DST investments are generally inappropriate for retirees or conservative investors who need liquidity, predictable income, or capital preservation — yet these are the very investors to whom such products are frequently marketed.

An unsuitable recommendation, or a misrepresentation about the nature and risks of a DST investment, may give rise to a claim against the recommending broker or brokerage firm through FINRA arbitration.

Investors who wish to discuss a possible claim may contact a securities arbitration lawyer at the Law Office of Christopher J. Gray, P.C. at (866) 966-9598 or via email at newcases@investorlawyers.net for a no-cost, confidential consultation.   The firm has handled numerous cases involving securities and commodities, both in state and federal court and in arbitration. Attorneys at the firm are admitted in New York, Wisconsin and various federal courts around the country, and handle cases nationwide (in cooperation with attorneys located in those states when required by applicable rules).